The Patent Finder
US

Contact Lens

US D671,580 In force
OverviewFamilyAssignmentsSources & methods

Term ends Nov 27, 2026 · High confidence

No current holder resolved from the recorded chain.
Filed May 4, 2012 as application 29/420,128 · Granted Nov 27, 2012
Base term, 14 years from grant
Today
14 years from grant
2012 2026
Clock starts
Nov 27, 2012
Term ends
Nov 27, 2026
base term Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
14 years from grant
Base term
No maintenance fees are payable on this kind of patent.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its base term, 14 years from grant, with no adjustment for prosecution delay. No maintenance fees are payable on this kind of patent. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 14 years from grantGranted Nov 27, 2012Nov 27, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Computed term endThe steps above, in orderNov 27, 2026High confidence

This family

Application 29/401,990Abandoned
not computed
not computed
US D671,580this patent
Nov 2026
Nov 2026
The applications whose file history this site holds. The family may have others.

Assignments

The 40 most recent of 92 recorded documents are shown; the 52 earliest are not. Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health, Canada Inc. / Sante Bausch, Canada Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentICN Polfa Rzeszow Spolka Akcyjna (A/K/A ICN Polfa Rzeszow S.A.)Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentOrapharma, Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentPrzedsiebiorstwo Farmaceutyczne Jelfa Spolka Akcyjna (A/K/A Przedsiebiorstwo Farmaceutyczne Jelfa S.A.)Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentSolta Medical Dutch Holdings B.V.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentV-Bac Holding Corp.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentVRX Holdco LLCRelease of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral Agent1261229 B.C. Ltd.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral Agent1530065 B.C. Ltd.Release of Security Interest
Jul 1, 2025
Reel 71773, frame 871
Bausch & Lomb Incorporated; Alden Optical Laboratories, Inc.; Bausch + Lomb Ireland LimitedCitibank, N.A., as Notes Collateral AgentPatent Security Agreement
Aug 14, 2025
Reel 72469, frame 91
Citibank, N.A., as Resigning AgentJPMorgan Chase Bank, N.A., as Successor AgentAssignment of Security Interest in Patents Previously Recorded at Reel/Frame (059913/0548)
Nov 20, 2025
Reel 73637, frame 1
The Bank of New York Mellon, as Notes Collateral AgentAton Pharma, Inc.; Bausch & Lomb Incorporated; Bausch & Lomb Pharma Holdings Corp.; Commonwealth Laboratories, LLC; Dow Pharmaceutical Sciences, Inc.; Ecr Pharmaceuticals Co., Inc.; Laboratoire Chauvin S.A.S.; Medicis Pharmaceutical Corporation; Onpharma Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Ltd.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Solta Medical, Inc.; Synergetics USA, Inc.; Technolas Perfect Vision GmbH; Valeant Canada LP; Valeant Pharmaceuticals International; Valeant Pharmaceuticals International, Inc.; Valeant Pharmaceuticals North America LLC; Wirra IP Pty Limited; Valeant Pharma Poland SP. Z O.O.; Valeant Pharmaceuticals Luxembourg S.A R.L.; Valeant Pharmaceuticals Ireland LimitedRelease of Security Interest
Nov 20, 2025
Reel 73654, frame 242
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentAton Pharma, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb IncorporatedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb Pharma Holdings Corp.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentCommonwealth Laboratories, LLCRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentDow Pharmaceutical Sciences, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentEcr Pharmaceuticals Co., Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentLaboratoire Chauvin S.A.S.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentMedicis Pharmaceutical CorporationRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentOnpharma Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentOrapharma, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentPrecision Dermatology, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Ltd.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSantarus, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSolta Medical, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSynergetics USA, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentTechnolas Perfect Vision GmbHRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Canada LPRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals InternationalRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals International, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals North America LLCRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentWirra IP Pty LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharma Poland SP. Z O.O.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals Luxembourg S.A R.L.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals Ireland LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health US, LLCRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center

No maintenance fees are payable on this kind of patent, so the record carries no fee events.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited